Editorial: targeting aberrant hepatic inflammation for treatment of non‐alcoholic steatohepatitis
Alimentary pharmacology & therapeutics, 2022-02, Vol.55 (4), p.483-484 [Peer Reviewed Journal]2021 John Wiley & Sons Ltd ;ISSN: 0269-2813 ;EISSN: 1365-2036 ;DOI: 10.1111/apt.16748 ;PMID: 35092056
Full text available